Control of Lineage Commitment in Developing Thymocytes
胸腺细胞发育中谱系定型的控制
基本信息
- 批准号:8212191
- 负责人:
- 金额:$ 44.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-06-01 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAdultAffectAffinityAgeAnimalsAntibodiesBlood CellsCD4 Positive T LymphocytesCD44 geneCD8B1 geneCell Differentiation processCell LineageCell MaturationCellsCessation of lifeCharacteristicsChildhood LeukemiaDataDefectDevelopmentDiseaseEmployee StrikesEventExhibitsFetusGeneticGenetic TranscriptionGrowthHealthHematopoieticHumanIn VitroIncidenceLigandsLymphoidLymphomaLymphomagenesisMaintenanceMalignant NeoplasmsMediatingMediator of activation proteinModelingMonoclonal Antibody HuM291MusMutationOncogenesPhenotypePhysiologicalPlayPopulationProcessRegulatory ElementReporterRoleSeriesSignal TransductionStagingT-Cell DevelopmentT-LymphocyteTestingThymic LymphomaThymocyte DevelopmentThymocyte SelectionThymus GlandTransgenesTransgenic MiceTransgenic OrganismsTrue Thymic HyperplasiaTumor Suppressor GenesUrsidae Familybasecell typefetalin uteroin vivoin vivo Modelmonolayernovelprematurepublic health relevanceresearch studyresponsesingle cell analysisthymocytetranscription factortumortumor initiation
项目摘要
DESCRIPTION (provided by applicant): Hitherto, the expression of ThPOK in T cell development was believed to be restricted to the ab T cell lineage, in particular to transitional CD4+8lo thymocytes and SP CD4 cells in the thymus and periphery. We now show that a subset of gdTCR+ thymocytes also expresses ThPOK, and that ThPOK expression correlates largely with expression of the activation marker CD44. Furthermore, ThPOK is expressed in KN6 gdTCR transgenic mice in the presence of high but not low affinity ligands. These observations suggest that ThPOK is induced in gd thymocytes in response to strong TCR signals. Significantly, HD-/- mice, which lack functional ThPOK, show a severe defect in development of mature gd thymocytes, while mice expressing ThPOK constitutively show a striking increase, establishing an important role for ThPOK in maturation and/or lineage commitment of gd cells. Given that the importance of TCR signaling and selection for gd development remains highly controversial, establishing a critical role for ThPOK in these processes would represent a significant advance. Hence in Aims 1 and 2 of the current proposal, we propose to address whether ThPOK induction in gd thymocytes is directly regulated by TCR signaling, and whether ThPOK controls positive/negative selection of gd thymocytes and/or commitment to the gd lineage. Interestingly, while ThPOK appears to be required for normal gd development, its expression in preTCR-expressing DN thymocytes leads to a high incidence of thymic lymphomas. In Aim 3 we propose to identify the cell type and stage in ontogeny at which lymphomagenesis is initiated, and test whether gdTCR expression or gd commitment are sufficient to protect DN thymocytes against ThPOK-mediated lymphomagenesis.
PUBLIC HEALTH RELEVANCE: The current proposal deals with the process by which T cells develop to the distinct gd lineage, which we show is controlled by a key transcription factor called ThPOK. How ThPOK controls this process is unknown and the subject of this proposal. Unregulated expression of ThPOK causes blood cell cancer, so that understanding its function is of direct relevance to health.
描述(由申请人提供):迄今为止,T细胞发育中ThPOK的表达被认为限于ab T细胞谱系,特别是胸腺和外周中的过渡性CD4+8lo胸腺细胞和SP CD4细胞。我们现在表明 gdTCR+ 胸腺细胞的一个子集也表达 ThPOK,并且 ThPOK 表达在很大程度上与激活标记 CD44 的表达相关。此外,ThPOK 在高亲和力配体存在但不存在低亲和力配体的情况下在 KN6 gdTCR 转基因小鼠中表达。这些观察结果表明,gd 胸腺细胞响应强 TCR 信号而诱导 ThPOK。值得注意的是,缺乏功能性 ThPOK 的 HD-/- 小鼠在成熟 gd 胸腺细胞的发育中表现出严重缺陷,而表达 ThPOK 的小鼠则表现出显着的增加,从而确立了 ThPOK 在 gd 细胞成熟和/或谱系定型中的重要作用。鉴于 TCR 信号传导和选择对 gd 发育的重要性仍然存在很大争议,确定 ThPOK 在这些过程中的关键作用将代表着重大进步。因此,在当前提案的目标1和2中,我们建议解决gd胸腺细胞中的ThPOK诱导是否直接受TCR信号调节,以及ThPOK是否控制gd胸腺细胞的正/负选择和/或对gd谱系的承诺。有趣的是,虽然 ThPOK 似乎是正常 gd 发育所必需的,但其在表达 preTCR 的 DN 胸腺细胞中的表达导致胸腺淋巴瘤的高发病率。在目标 3 中,我们建议鉴定淋巴瘤发生起始的细胞类型和个体发育阶段,并测试 gdTCR 表达或 gd 定型是否足以保护 DN 胸腺细胞免受 ThPOK 介导的淋巴瘤发生。
公共健康相关性:当前提案涉及 T 细胞发育成独特 gd 谱系的过程,我们表明该谱系由称为 ThPOK 的关键转录因子控制。 ThPOK 如何控制此过程尚不清楚,也是本提案的主题。 ThPOK 表达失控会导致血细胞癌,因此了解其功能与健康直接相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dietmar J Kappes其他文献
CD4-CD8 lineage commitment: an inside view
CD4-CD8 谱系承诺:内部视角
- DOI:
10.1038/ni1230 - 发表时间:
2005-07-20 - 期刊:
- 影响因子:27.600
- 作者:
Dietmar J Kappes;Xiao He;Xi He - 通讯作者:
Xi He
ERK2 Substrate Binding Domains Play Distinct Roles in Megakaryocytic-Erythroid Lineage Progression and Mediates Clonal Fitness in Myeloproliferative Neoplasms
- DOI:
10.1182/blood-2022-170264 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Billy Truong;Yong Zhang;Esteban Martinez;Brianna Trankle;Anna-Mariya Kukuyan;Susan Shinton;James Oesterling;Xiang Hua;Dietmar J Kappes;Joan Font-Burgada;Tomasz Skorski;David Wiest - 通讯作者:
David Wiest
New ingredients for brewing CD4+T (cells): TCF-1 and LEF-1
用于酿造 CD4+T(细胞)的新成分:TCF-1 和 LEF-1
- DOI:
10.1038/ni.2927 - 发表时间:
2014-06-18 - 期刊:
- 影响因子:27.600
- 作者:
Jayati Mookerjee-Basu;Dietmar J Kappes - 通讯作者:
Dietmar J Kappes
Dietmar J Kappes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dietmar J Kappes', 18)}}的其他基金
Role of ThPOK in HSC Maintenance and Leukemogenesis
ThPOK 在 HSC 维持和白血病发生中的作用
- 批准号:
9025082 - 财政年份:2015
- 资助金额:
$ 44.83万 - 项目类别:
Dissecting Distinct and Redundant Roles of ThPOK and LRF, Key Regulators of Hematopoiesis
剖析造血关键调节因子 ThPOK 和 LRF 的不同和冗余作用
- 批准号:
9130273 - 财政年份:2015
- 资助金额:
$ 44.83万 - 项目类别:
Dissecting the role of ThPOK in thymic development and T cell differentiation
剖析 ThPOK 在胸腺发育和 T 细胞分化中的作用
- 批准号:
9322576 - 财政年份:2014
- 资助金额:
$ 44.83万 - 项目类别:
Dissecting the role of ThPOK in thymic development and T cell differentiation
剖析 ThPOK 在胸腺发育和 T 细胞分化中的作用
- 批准号:
8704657 - 财政年份:2014
- 资助金额:
$ 44.83万 - 项目类别:
Molecular Triggers of T Helper Lineage Choice
T 辅助细胞谱系选择的分子触发因素
- 批准号:
7508052 - 财政年份:2009
- 资助金额:
$ 44.83万 - 项目类别:
Molecular Triggers of T Helper Lineage Choice
T 辅助细胞谱系选择的分子触发因素
- 批准号:
7847576 - 财政年份:2009
- 资助金额:
$ 44.83万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 44.83万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 44.83万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 44.83万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 44.83万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 44.83万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 44.83万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 44.83万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 44.83万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 44.83万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 44.83万 - 项目类别:














{{item.name}}会员




